The Nigerian Ministry of Health, in partnership with Pfizer, the Clinton Health Access Initiative (CHAI), American Cancer Society (ACS) and others, launched the Chemotherapy Access Partnership to deliver lifesaving chemotherapy medicines in seven teaching hospitals across Nigeria. The program gives Nigerians access to lower-priced, high-quality chemotherapy medications – the same ones available today in the developed world – to help address the estimated 100,000 cases and 70,000 deaths due to cancer in the country each year.1
This is the first major government-backed initiative under Pfizer's ground-breaking access agreement with CHAI and ACS, which offers access to high-quality Pfizer chemotherapy medications at almost 50% lower cost in Nigeria, Kenya, Ethiopia, Rwanda, Tanzania, Uganda, Zambia, Zimbabwe and Malawi.